Amsterdam-based medical technology company Nicolab is launching a $6 million pre-IPO fundraising round to support its latest attempt at listing on the Australian Securities Exchange (ASX).
The company is targeting a public debut in 2027, marking its third effort to go public since initial attempts began in 2018.
The capital raise is designed to fund the regulatory and advisory costs associated with the listing process.
Nicolab has faced a prolonged path to the public markets, with previous efforts stalling over the years.
This latest move signals renewed commitment to accessing Australian capital markets, likely driven by the region's strong appetite for healthcare and medtech equities.
The push for an ASX listing comes as other medical technology firms are also advancing their public market strategies.